LOS ANGELES, Sept. 25, 2017 -- Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against MAXIMUS, Inc. (“MAXIMUS” or the “Company”) (NYSE:MMS) for possible violations of federal securities laws from October 30, 2014 through February 3, 2016, inclusive (the “Class Period”). Investors who purchased or otherwise acquired MAXIMUS shares during the Class Period should contact the firm prior to the October 6, 2017 lead plaintiff motion deadline.
To participate in this class action lawsuit, click here.
You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or e-mail him at [email protected].
No class has been certified in the above action yet. Until a class is certified, you are not considered to be represented by an attorney. You may also choose to do nothing and be an absent class member.
The Complaint alleges that throughout the Class Period, MAXIMUS made false and/or misleading statements and/or failed to disclose that: in obtaining the Health Assessment Advisory Service (“HAAS”) contract, the Company set an unattainable target number of healthcare professionals to recruit and an unattainable target number of assessments; that throughout the HAAS contract, MAXIMUS was struggling to recruit, train and ramp-up new health care staff to perform the assessments; that the inability to meet its target number of healthcare recruits and target number of assessments, meant MAXIMUS would not earn the performance-based incentive fees from the HAAS contract; and that as a result, the Company’s statements about its financial condition, and the outlook for its business, including statements about the HAAS contract and the amount of revenue MAXIMUS expected the contract to contribute, lacked a reasonable basis when made. Upon release of this news, MAXIMUS’ stock price fell materially, which harmed investors according to the lawsuit.
Lundin Law PC was founded by Brian Lundin, Esq., a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.
This press release may constitute Attorney Advertising in certain jurisdictions under the applicable law and ethics rules.
Contact:
Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
[email protected]
http://lundinlawpc.com/


FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
FDA Approves Mitapivat for Anemia in Thalassemia Patients
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Winter Storm Devin Triggers Massive Flight Cancellations and Travel Disruptions Across the U.S.
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
California DMV Proposes New Safety Rules for Autonomous Vehicles After Waymo Incidents 



